Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04941_nanopub.RAN81-FhLRXZ-2cl-8_C3z9_awV9_khAylSOcWOnhUgrg#assertion>. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB04941 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04941 label "Crofelemer [drugbank:DB04941]" assertion.
- drugbank:DB04941 seeAlso DB04941 assertion.
- drugbank:DB04941 seeAlso crofelemer-side-effects.html assertion.
- drugbank:DB04941 seeAlso fulyzaq-drug.htm assertion.
- drugbank:DB04941 identifier "drugbank:DB04941" assertion.
- drugbank:DB04941 description "Crofelemer, previously known as the investigational drug SP-303, is a novel proanthocyanidin purified from the bark latex of the Amazonian Croton tree <i>Croton lechleri</i>. It is marketed under the brand name Fulyzaq and indicated for the symptomatic treatment of non-infectious diarrhea in adult patients with HIV/AIDS who are taking antiretroviral therapy." assertion.
- drugbank:DB04941 title "Crofelemer" assertion.
- drugbank:DB04941 bio2rdf_vocabulary:identifier "DB04941" assertion.
- drugbank:DB04941 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04941 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04941" assertion.
- drugbank:DB04941 bio2rdf_vocabulary:x-identifiers.org DB04941 assertion.
- drugbank:DB04941 drugbank_vocabulary:drugbank-id "DB04941" assertion.
- drugbank:DB04941 drugbank_vocabulary:x-cas cas:148465-45-6 assertion.
- drugbank:DB04941 drugbank_vocabulary:x-kegg kegg:D03605 assertion.
- drugbank:DB04941 drugbank_vocabulary:x-wikipedia wikipedia:Crofelemer assertion.
- drugbank:DB04941 drugbank_vocabulary:x-ndc ndc:65649-802-02 assertion.